Convenient oral dosing, with or without food¹

RECOMMENDED STARTING DOSE: 400 mg twice daily
AM: two 200-mg tablets Not actual size.	PM: two 200-mg tablets Not actual size.

• TABRECTA^® (capmatinib) tablets can be taken with or without food

• Swallow TABRECTA^® (capmatinib) tablets whole. Do not break, crush, or chew the tablets

• If a patient misses or vomits a dose, instruct the patient not to make up the dose, but to take the next dose as its scheduled time

Dosing can be modified to manage adverse reactions¹

FIRST DOSE REDUCTION: 300 mg twice daily	SECOND DOSE REDUCTION: 200 mg twice daily
AM: two 150-mg tablets PM: two 150-mg tablets Not actual size.	AM: one 200-mg tablet PM: one 200-mg tablet Not actual size.

• Permanently discontinue TABRECTA^® (capmatinib) tablets in patients who are unable to tolerate 200 mg orally twice daily

• Patients with mild to moderate renal impairment do not require dose modifications 

TABRECTA^® (capmatinib) tablets is available in 2 strengths¹

200 mg NDC 0078-0716-56 Not actual size.

150 mg NDC 0078-0709-56 Not actual size.

How to prescribe TABRECTA^® (capmatinib) tablets¹

Storage and handling¹

• Dispense in the original package with the desiccant cartridge

• Store at room temperature^* and protect from moisture

• Discard any unused TABRECTA^® (capmatinib) tablets remaining after 6 weeks of first opening the bottle

Next: Resources >